<?xml version="1.0" encoding="UTF-8"?>
<mods xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.1" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
  <titleInfo>
    <title>Pharmaceutical industry</title>
    <subTitle>innovation and developments</subTitle>
  </titleInfo>
  <name type="personal">
    <namePart>Mancuso, David A.</namePart>
  </name>
  <name type="personal">
    <namePart>Grenada, Isobel M.</namePart>
  </name>
  <name type="corporate">
    <namePart>ebrary, Inc</namePart>
  </name>
  <typeOfResource>text</typeOfResource>
  <genre authority="marc">bibliography</genre>
  <genre authority="local">Electronic books.</genre>
  <originInfo>
    <place>
      <placeTerm type="code" authority="marccountry">nyu</placeTerm>
    </place>
    <place>
      <placeTerm type="text">Hauppauge, N.Y</placeTerm>
    </place>
    <publisher>Nova Science</publisher>
    <dateIssued>c2011</dateIssued>
    <dateIssued encoding="marc">2011</dateIssued>
    <issuance>monographic</issuance>
  </originInfo>
  <language>
    <languageTerm authority="iso639-2b" type="code">eng</languageTerm>
  </language>
  <physicalDescription>
    <form authority="marcform">electronic</form>
    <form authority="gmd">electronic resource</form>
    <extent>ix, 182 p. : ill.</extent>
  </physicalDescription>
  <tableOfContents>Authorized generic pharmaceuticals : effects on innovation / John R. Thomas -- Authorized generics : an interim report / FTC -- Remarks of J. Thomas Rosch, Commissioner, Federal Trade Commission, before the World Generic Medicine Congress, hearing on "pay-for-delay settlements, authorized generics, and follow-on biologies : thoughts on the how competition law can best protect consumer welfare in the pharmaceutical context" -- Federal R&amp;D, drug discovery, and pricing : insights from the NIH-university-industry relationship / Wendy H. Schacht -- Pharmaceutical R&amp;D and the evolving market for prescription drugs / CBO -- Federal taxation of the drug industry and its effects on new drug development / Gary Guenther -- Pharmaceutical patent litigation settlements : implications for competition and innovation / John R. Thomas -- FDA's authority to regulate drug compounding : a legal analysis / Jennifer Staman -- Promotional spending for prescription drugs / CBO.</tableOfContents>
  <note type="statement of responsibility">David A. Mancuso and Isobel M. Grenada, editors.</note>
  <note>Includes bibliographical references and index.</note>
  <note>Electronic reproduction. Palo Alto, Calif. : ebrary, 2013. Available via World Wide Web. Access may be limited to ebrary affiliated libraries.</note>
  <subject authority="lcsh">
    <topic>Drug development</topic>
  </subject>
  <subject authority="lcsh">
    <topic>Pharmaceutical industry</topic>
  </subject>
  <subject authority="lcsh">
    <topic>Drugs</topic>
    <topic>Law and legislation</topic>
  </subject>
  <classification authority="lcc">RM301.25 .P428 2011eb</classification>
  <classification authority="ddc" edition="22">615/.19</classification>
  <relatedItem type="series">
    <titleInfo>
      <title>Business issues, competition and entrepreneurship series</title>
    </titleInfo>
  </relatedItem>
  <relatedItem type="series">
    <titleInfo>
      <title>Pharmacology-research, safety testing, and regulation series</title>
    </titleInfo>
  </relatedItem>
  <identifier type="isbn" invalid="yes"/>
  <identifier type="isbn" invalid="yes"/>
  <identifier type="lccn" invalid="yes"/>
  <identifier type="uri">http://site.ebrary.com/lib/rucke/Doc?id=10683067</identifier>
  <location>
    <url>http://site.ebrary.com/lib/rucke/Doc?id=10683067</url>
  </location>
  <recordInfo>
    <recordContentSource authority="marcorg">CaPaEBR</recordContentSource>
    <recordCreationDate encoding="marc">110125</recordCreationDate>
    <recordIdentifier source="CaPaEBR">ebr10683067</recordIdentifier>
  </recordInfo>
</mods>
